DK1255557T3 - Stabil, nasal, oral eller sublingual anvendelig farmaceutisk tilberedning indeholdende desmopressin - Google Patents

Stabil, nasal, oral eller sublingual anvendelig farmaceutisk tilberedning indeholdende desmopressin

Info

Publication number
DK1255557T3
DK1255557T3 DK01901008T DK01901008T DK1255557T3 DK 1255557 T3 DK1255557 T3 DK 1255557T3 DK 01901008 T DK01901008 T DK 01901008T DK 01901008 T DK01901008 T DK 01901008T DK 1255557 T3 DK1255557 T3 DK 1255557T3
Authority
DK
Denmark
Prior art keywords
sublingually
stable
pharmaceutical preparation
nasal
oral
Prior art date
Application number
DK01901008T
Other languages
English (en)
Inventor
Thomas Zapf
Helmut Scheidl
Gerhard Hantich
Ernst Hesse
Original Assignee
Gebro Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3669975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1255557(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gebro Pharma Gmbh filed Critical Gebro Pharma Gmbh
Application granted granted Critical
Publication of DK1255557T3 publication Critical patent/DK1255557T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01901008T 2000-02-16 2001-01-10 Stabil, nasal, oral eller sublingual anvendelig farmaceutisk tilberedning indeholdende desmopressin DK1255557T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0023300A AT409081B (de) 2000-02-16 2000-02-16 Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
PCT/AT2001/000007 WO2001060394A1 (de) 2000-02-16 2001-01-10 Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung

Publications (1)

Publication Number Publication Date
DK1255557T3 true DK1255557T3 (da) 2004-03-22

Family

ID=3669975

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01901008T DK1255557T3 (da) 2000-02-16 2001-01-10 Stabil, nasal, oral eller sublingual anvendelig farmaceutisk tilberedning indeholdende desmopressin

Country Status (20)

Country Link
US (1) US20030119728A1 (da)
EP (1) EP1255557B1 (da)
JP (1) JP2003529562A (da)
AT (2) AT409081B (da)
AU (1) AU771251B2 (da)
CA (1) CA2399822A1 (da)
CZ (1) CZ20022686A3 (da)
DE (1) DE50100958D1 (da)
DK (1) DK1255557T3 (da)
ES (1) ES2210121T3 (da)
HU (1) HU229961B1 (da)
NO (1) NO20023875L (da)
NZ (1) NZ520396A (da)
PL (1) PL357132A1 (da)
PT (1) PT1255557E (da)
SI (1) SI21026B (da)
SK (1) SK285374B6 (da)
TR (1) TR200400234T4 (da)
WO (1) WO2001060394A1 (da)
ZA (1) ZA200205868B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003269747A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
AT413078B (de) * 2002-10-10 2005-11-15 Gebro Pharma Gmbh Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP1500390B1 (en) 2003-07-25 2005-08-17 Ferring B.V. Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof
ATE324869T1 (de) * 2003-11-13 2006-06-15 Ferring Bv Blisterverpackung und feste dosierungsform enthaltend desmopressin
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
JP5079257B2 (ja) * 2005-05-16 2012-11-21 株式会社三和化学研究所 Ｂｕｒｋｈｏｌｄｅｒｉａｃｅｐａｃｉａに対する保存剤
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
ES2319054B1 (es) * 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
WO2009021007A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
SI3085381T1 (en) 2008-05-21 2018-06-29 Ferring B.V. Orodispersible desmopressin to increase the initial sleep period without disturbing the nostrils
JO3400B1 (ar) 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
JP2011116764A (ja) * 2011-02-08 2011-06-16 Fine Seymour H 低用量デスモプレシンを含有する医薬組成物
CN114376970A (zh) 2013-06-28 2022-04-22 美国安进公司 Etelcalcetide (AMG 416)的稳定的液体制剂
JP6341777B2 (ja) * 2014-06-30 2018-06-13 リプリーズ バイオファーマシューティクス，エルエルシー 低用量デスモプレシンを含有する医薬組成物
JP2017535567A (ja) * 2014-11-20 2017-11-30 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ アルファ−アドレナリン受容体拮抗薬と組み合わせたデスモプレシンを含む方法及び組成物
GB201721846D0 (en) * 2017-12-22 2018-02-07 Arecor Ltd Novel composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61126014A (ja) * 1984-11-22 1986-06-13 Teijin Ltd 経鼻投与用水性液剤
JP2505430B2 (ja) * 1986-11-04 1996-06-12 帝人株式会社 塩基性アミノ酸を含有する経鼻投与用粉末状組成物
ES2067624T3 (es) * 1989-11-16 1995-04-01 Ph & T S R L Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.
CA2070061C (en) * 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
JPH0640948A (ja) * 1992-07-20 1994-02-15 Kyowa Hakko Kogyo Co Ltd イオントフォレシス用組成物
JP3628713B2 (ja) * 1993-06-07 2005-03-16 帝國製薬株式会社 生理学的に活性なペプチドを含有する膣投与製剤
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
CA2329004C (en) * 1998-06-30 2009-04-14 Takeda Chemical Industries, Ltd. Combination of insulin sensitizer with anorectic for treating or preventing diabetes
EP1185710A2 (en) * 1999-04-16 2002-03-13 Zymetx, Inc. Viral detection method using viral encoded enzymes and chemiluminescent substrates
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003269747A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide

Also Published As

Publication number Publication date
WO2001060394A1 (de) 2001-08-23
EP1255557B1 (de) 2003-11-12
CZ20022686A3 (cs) 2003-01-15
HUP0204550A3 (en) 2004-12-28
EP1255557A1 (de) 2002-11-13
AU2652001A (en) 2001-08-27
PL357132A1 (en) 2004-07-12
SI21026B (sl) 2004-02-29
JP2003529562A (ja) 2003-10-07
US20030119728A1 (en) 2003-06-26
NO20023875D0 (no) 2002-08-15
SK285374B6 (sk) 2006-12-07
HUP0204550A2 (en) 2003-05-28
SI21026A (sl) 2003-04-30
AU771251B2 (en) 2004-03-18
HU229961B1 (hu) 2015-03-30
PT1255557E (pt) 2004-04-30
DE50100958D1 (de) 2003-12-18
ATE253928T1 (de) 2003-11-15
NZ520396A (en) 2004-05-28
CA2399822A1 (en) 2001-08-23
AT409081B (de) 2002-05-27
ES2210121T3 (es) 2004-07-01
ATA2332000A (de) 2001-10-15
SK10492002A3 (sk) 2003-02-04
ZA200205868B (en) 2004-02-10
NO20023875L (no) 2002-10-11
TR200400234T4 (tr) 2004-03-22

Similar Documents

Publication Publication Date Title
DK1255557T3 (da) Stabil, nasal, oral eller sublingual anvendelig farmaceutisk tilberedning indeholdende desmopressin
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
ATE468845T2 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
BRPI0501101A (pt) Dispositivo de cabeçote de fio dental com um meio de administração de agente de sabor
NO20022201L (no) Lösninger inneholdende Epinastin
BRPI0410116A (pt) tablete de cuidado oral
TR200003688T1 (tr) Glutation'un absorbsıyonu'nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon
ES2171440T3 (es) Composicion solida mucoadhesiva, terapeutica o higienica, para administracion por aplicacion sobre la mucosa bucal o nasal.
MX166102B (es) Composiciones estabilizadas de fluoruro estannoso para el ciudado oral y metodo para su preparacion
BR0014878A (pt) Composição farmacêutica contendo ciclosonida para aplicação à mucosa
DK1121145T3 (da) Insulinpræparater til indgivelse via lungerne, som indeholder mentol
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
HRP20010764B1 (en) Prucalopride oral solution
HUP9900507A2 (hu) Levobupivacaine alkalmazása terhesség esetén használható érzéstelenítő hatású gyógyszerkészítmények előállítására
ES2159967T3 (es) Medicamento que contiene acido delta-aminolevulinico.
TR200102087T2 (tr) Yeni morfolinbenzamid tuzları
ATE408413T1 (de) Pralmorelin-haltige nasentropfen-präparate
PT1150660E (pt) Formulacao farmaceutica efervescente contendo metamizole
RU2003116945A (ru) Зубная паста
ATE231391T1 (de) Orale pharmazeutische zubereitung enthaltend paracetamol und metoclopramid
ES2189639B1 (es) Composicion acuosa que contiene acido acetilsalicilico.
RU2000129279A (ru) Состав для фиксации съемных зубных протезов
BG107987A (bg) Течна форма на комбинирано лекарствено средство за лечение на простудни и грипни заболявания